[{"NetIncomeLoss_1_Q2_USD":-41001000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":22907000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":15462000.0,"RestrictedCashCurrent_0_Q2_USD":300000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":3682000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-6000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":3000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-452638000.0,"Depreciation_2_Q2_USD":3198000.0,"PaymentsToAcquireInvestments_2_Q2_USD":635400000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":null,"PaymentsForRent_2_Q2_USD":3700000.0,"PaymentsForRent_1_Q2_USD":1800000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":7952000.0,"AssetsCurrent_0_Q2_USD":1189136000.0,"LongTermDebt_0_Q2_USD":895762000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":55198000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":28580000.0,"ShareBasedCompensation_2_Q2_USD":25970000.0,"Assets_0_Q2_USD":1245781000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":880940000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":9050000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":895762000.0,"CommonStockSharesIssued_0_Q2_shares":198917000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":25311000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":2968000.0,"AvailableForSaleSecurities_0_Q2_USD":1144373000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":16857000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":32877000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":29060000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":7781000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":25311000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":40075000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42815000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":22266000.0,"GainLossOnContractTermination_2_Q2_USD":-52000000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":50615000.0,"EarningsPerShareBasic_2_Q2_USD":-0.65,"EarningsPerShareBasic_1_Q2_USD":-0.21,"ProceedsFromSaleOfAvailableForSaleSecurities_2_Q2_USD":34557000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":150175000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-91000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-80000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":196690000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":198568000.0,"AssetsFairValueDisclosure_0_Q2_USD":1147673000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":5560000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":225000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":161000.0,"AccountsReceivableNetCurrent_0_Q2_USD":19936000.0,"Liabilities_0_Q2_USD":987536000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":35431000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":459794000.0,"OtherAssetsNoncurrent_0_Q2_USD":65000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1403000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-41081000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":1144379000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-128527000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":246000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":4238000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":868601000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":306643000.0,"CommonStockValue_0_Q2_USD":199000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-1782000.0,"IncreaseDecreaseInInventories_2_Q2_USD":5030000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":3705000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":-932000.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":1014300000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.65,"EarningsPerShareDiluted_1_Q2_USD":-0.21,"InvestmentsFairValueDisclosure_0_Q2_USD":684579000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":5500000.0,"AmortizationOfFinancingCosts_2_Q2_USD":227000.0,"AmortizationOfFinancingCosts_1_Q2_USD":151000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":25970000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":15805000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38816000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":5253000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":196690000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":198568000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":7579000.0,"LiabilitiesCurrent_0_Q2_USD":45433000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":377147000.0,"AccountsPayableCurrent_0_Q2_USD":4761000.0,"InterestExpense_2_Q2_USD":5378000.0,"NetIncomeLoss_2_Q2_USD":-128436000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":25000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":2144000.0,"AdditionalPaidInCapital_0_Q2_USD":1423357000.0,"GrossProfit_1_Q2_USD":13753000.0,"CommonStockSharesOutstanding_0_Q2_shares":198917000.0,"GrossProfit_2_Q2_USD":26730000.0,"InterestExpenseDebt_2_Q2_USD":5290000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":459794000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6542000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-9402000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":463094000.0,"InterestExpense_1_Q2_USD":3589000.0,"InterestExpenseDebt_1_Q2_USD":3526000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromConvertibleDebt_2_Q2_USD":895536000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1165305000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":10540000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":8136000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":307000.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":59607000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":30610000.0,"OperatingIncomeLoss_2_Q2_USD":-71283000.0,"OperatingIncomeLoss_1_Q2_USD":-37573000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":574297000.0,"InventoryNet_0_Q2_USD":17985000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":9534000.0,"PreferredStockValue_0_Q2_USD":null,"OperatingLeaseCost_2_Q2_USD":3100000.0,"OperatingLeaseCost_1_Q2_USD":1600000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1245781000.0,"PreferredStockSharesAuthorized_0_Q2_shares":50000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":25970000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":226000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":30610000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":59607000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":3300000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":900000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1970000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":3099000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":10158000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3587000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":752000.0,"OperatingExpenses_1_Q2_USD":51326000.0,"OperatingExpenses_2_Q2_USD":98013000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4644000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":15805000.0,"StockholdersEquity_0_Q2_USD":258245000.0,"ShortTermInvestments_0_Q2_USD":684579000.0,"Ticker":"PACB","CIK":"1299130","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","OfficialName":"Pacific Biosciences of California Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1643385656.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]